Publications by authors named "M List"

Degree distributions in protein-protein interaction (PPI) networks are believed to follow a power law (PL). However, technical and study biases affect the experimental procedures for detecting PPIs. For instance, cancer-associated proteins have received disproportional attention.

View Article and Find Full Text PDF

Motivation: The availability of longitudinal omics data is increasing in metabolomics research. Viewing metabolomics data over time provides detailed insight into biological processes and fosters understanding of how systems react over time. However, the analysis of longitudinal metabolomics data poses various challenges, both in terms of statistical evaluation and visualization.

View Article and Find Full Text PDF
Article Synopsis
  • DysRegNet is a new method designed to analyze patient-specific gene-regulatory networks, addressing limitations of existing methods that don't consider important factors like age and treatment history, and that struggle with large samples.
  • The method shows improved scalability and relevance by highlighting age-specific biases in gene regulation, particularly in breast cancer, while generating interpretable results comparable to the established SSN method.
  • DysRegNet is accessible as a Python package and offers an interactive web interface for analyzing results from various cancer types, making it a useful tool for personalized medicine and bioinformatics research.
View Article and Find Full Text PDF

Non-healing bone defects are a pressing public health concern accounting for one main cause for decreased life expectancy and quality. An aging population accompanied with increasing incidence of comorbidities, foreshadows a worsening of this socio-economic problem. Conventional treatments for non-healing bone defects prove ineffective for 5%-10% of fractures.

View Article and Find Full Text PDF

Artificial intelligence (AI) has the potential to transform clinical practice and healthcare. Following impressive advancements in fields such as computer vision and medical imaging, AI is poised to drive changes in microbiome-based healthcare while facing challenges specific to the field. This review describes the state-of-the-art use of AI in microbiome-related healthcare.

View Article and Find Full Text PDF